Cormorant Asset Management LP 13D and 13G filings for Revolution Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:10 pm Sale |
2021-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Cormorant Asset Management LP | 2,431,852 3.300% |
-1,243,148 (-33.83%) |
Filing |
| 2021-05-19 4:09 pm Purchase |
2021-05-18 | 13G | Revolution Medicines, Inc. RVMD |
Cormorant Asset Management LP | 3,675,000 5.000% |
1,179,934 (+47.29%) |
Filing |
| 2021-02-16 3:00 pm Sale |
2020-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Cormorant Asset Management LP | 2,495,066 3.800% |
-750,111 (-23.11%) |
Filing |